日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma

DNA拷贝数模式揭示了IDH突变型星形细胞瘤的预后标志物并阐明了其演变机制

Drucker, Kristen L; Panda, Arijit; Decker, Paul A; Kosel, Matt L; Kollmeyer, Thomas M; Burns, Terry C; Maqbool, Muhammad Asad; Shafqat, Shameel; Suvakov, Milovan; Zadeh, Gelareh; Giannini, Caterina; Vaubel, Rachael; Raghunathan, Aditya; Parney, Ian F; Kizilbash, Sani H; Ida, Cristiane M; Abyzov, Alexej; Lachance, Daniel H; Eckel-Passow, Jeanette E; Jenkins, Robert B

Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, IDH-wildtype

比较组织学和分子胶质母细胞瘤(IDH野生型)的临床、影像学和基因组改变

Lachance, Daniel H; Decker, Paul A; Kollmeyer, Thomas M; Drucker, Kristen L; Praska, Corinne E; Kosel, Matthew L; Odukoya, AbdulLateef A; Kizilbash, Sani H; Maqbool, Muhammad Asad; Shafqat, Shameel; Tobin, William Oliver; Parney, Ian F; Burns, Terry C; Galanis, Evanthia; Giannini, Caterina; Vaubel, Rachel A; Ida, Cris M; Jenkins, Robert B; Eckel-Passow, Jeanette E

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

MDM2抑制剂brigimadlin在胶质母细胞瘤患者来源异种移植模型中的药代动力学-药效学-疗效模型

Vaubel, Rachael A; Zhang, Wenjuan; Karbhari, Nishika; Oh, Ju-Hee; Waller, Katie L; Mladek, Ann; Jain, Sonia; Burgenske, Danielle M; Decker, Paul A; Kosel, Matt L; Hu, Zeng; Ott, Lauren L; Carlson, Brett L; Bakken, Katrina K; Pasa, Tugce; Sarkaria, Nicole R; Talele, Surabhi; Eckel-Passow, Jeanette E; Sini, Patrizia; Elmquist, William F; Sarkaria, Jann N

Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoring

脑脊液D-2-羟基戊二酸用于IDH突变型胶质瘤监测

Riviere-Cazaux, Cecile; Suzuki, Yuta; Kizilbash, Zain; Laxen, William J; Lacey, Jean M; Wipplinger, Tamara M; Warrington, Arthur E; Keough, Michael B; Kamga, Lionel Fotso; Andersen, Katherine M; Canaday, Nicholas; Kosel, Matthew L; Tortorelli, Silvia; Sener, Ugur; Ruff, Michael W; Decker, Paul A; Eckel-Passow, Jeanette E; Kizilbash, Sani H; Kaufmann, Timothy J; Burns, Terry C

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination

在多发性硬化症诊断标准中加入光学相干断层扫描对肿瘤样脱髓鞘疾病分类的影响

Guido, Fiorella S; Chen, John J; Decker, Paul A; Fereidan-Esfahani, Mahboubeh; Chodnicki, Kevin D; Tajfirouz, Deena A; Flanagan, Eoin P; Kantarci, Orhun H; Keegan, B Mark; Pittock, Sean J; Tillema, Jan-Mendelt; Lucchinetti, Claudia F; Eckel-Passow, Jeanette E; Tobin, W Oliver

Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett's Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

发现和验证用于区分非典型增生性巴雷特食管与高级别异型增生和食管腺癌的分子生物标志物

Matchett, Caroline L; Slettedahl, Seth W; Taylor, William R; Berger, Calise K; Anderson, Caryn E; Passe, Melissa A; Lansing, Ramona M; Wang, Panwen; Chalmers, Collin E; Foote, Patrick H; Eckel-Passow, Jeanette E; Sun, Zhifu; Mahoney, Douglas W; Codipilly, D Chamil; Leggett, Cadman L; Ramirez, Francisco C; Kahn, Allon; Wolfsen, Herbert C; Eluri, Swathi; Konda, Vani J A; Trindade, Arvind J; Iyer, Prasad G; Kisiel, John B

The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts

新型脑穿透性共济失调毛细血管扩张症突变抑制剂WSD0628可显著增强脑肿瘤患者来源异种移植瘤的放射敏感性。

Xue, Zhiyi; Mladek, Ann C; Rathi, Sneha; Jain, Sonia; Vaubel, Rachael A; Odukoya, Lateef A; Garcia, Darwin A; Liu, Lily; Bakken, Katrina K; Carlson, Brett L; Ott, Lauren L; Burgenske, Danielle M; Hu, Zeng; Dragojevic, Sonja; Decker, Paul A; Kosel, Matthew L; Breen, William G; Gupta, Shiv K; Eckel-Passow, Jeanette E; Elmquist, William F; Zhong, Wei; Sarkaria, Jann N

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

基于结构导向的FOXA1改变分类可识别具有相反临床结果和不同分子及免疫学亚型的前列腺癌

Hwang, Justin; Likasitwatanakul, Pornlada; Deshmukh, Sachin Kumar; Wu, Sharon; Kwon, Jason J; Toye, Eamon; Moline, David; Evans, Mark G; Elliott, Andrew; Passow, Rachel; Luo, Christine; John, Emily; Gandhi, Nishant; McKay, Rana R; Heath, Elisabeth I; Nabhan, Chadi; Reizine, Natalie; Orme, Jacob J; Domingo Domenech, Josep M; Sartor, Oliver; Baca, Sylvan C; Dehm, Scott M; Antonarakis, Emmanuel S

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type Glioblastoma.

Navtemadlin 在 IDH 野生型胶质母细胞瘤中的药代动力学、药效学和疗效的临床前模型

Vaubel Rachael A, Zhang Wenjuan, Oh Ju-Hee, Mladek Ann C, Pasa Tugce I, Gantchev Jennifer K, Waller Katie L, Baquer Gerard, Stopka Sylwia A, Regan Michael S, Hossain Md Amin, Decker Paul A, Kosel Matthew L, Gupta Shiv K, Jain Sonia, Sarkaria Paige P, Hu Zeng, Ott Lauren L, Carlson Brett L, Bakken Katie K, Talele Surabhi, Zhang Wenqiu, Ligon Keith L, Lee Eudocia Q, Eckel Passow Jeanette E, Burgenske Danielle M, Agar Nathalie Y R, Elmquist William F, Sarkaria Jann N

HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer

HLA I类分子的表达塑造肿瘤免疫微环境,并影响前列腺癌的预后。

Likasitwatanakul, Pornlada; Besonen, Carissa; Tsai, Alexander K; Sadeghipour, Negar; Elliott, Andrew; Arafa, Ali T; Passow, Rachel; Chesner, Lisa; Felices, Martin; Kennedy, Philippa R; Patnaik, Akash; Narayan, Vivek; Hamrick, James; Sena, Laura A; Zorko, Nicholas A; Hwang, Justin H; Antonarakis, Emmanuel S